Program to prevent rheumatic heart disease in Northern Uganda

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective study evaluates the feasibility and public health impact of a district-based program aimed at preventing Rheumatic Heart Disease (RHD) in Uganda. The initiative, known as ADUNU, implements decentralized RHD preventive services through community and facility-based echocardiographic screening for children and young adults. It also includes a registry-based secondary prophylaxis program using Benzathine penicillin G injections at local health centers. The study will assess the program's reach, effectiveness, adoption, implementation, and maintenance, as well as its cost-effectiveness.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* residing in one of two involved districts in Uganda
* providers at HCIIIs and HCIVs located in one of two involved Ugandan districts

Exclusion Criteria:

* None

Where it's running

• Uganda Heart Institute
  Kampala, Uganda, Uganda Recruiting

Study contacts

• Principal investigator: Andrea Z Beaton — Cincinnati Chidren's hospital
• Study coordinator: Ndate Fall
• Email: ndate.fall@cchmc.org
• Phone: 15135171327

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• School-based program to prevent rheumatic heart disease in kids

  This study tests a school-based nurse program and awareness effort to help children with latent rheumatic heart disease in three countries.

  Recruiting Centre for Infectious Disease Research in Zambia · Lusaka, Lusaka Province · NCT07927868

• Adapting and testing PEN-Plus in Zambian primary care

  Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.

  Recruiting Centre for Infectious Disease Research in Zambia · Lusaka, Lusaka Province · NCT07753681

• Stop penicillin in children with mild rheumatic heart disease to see if it’s still safe

  This study tests whether stopping secondary antibiotic prophylaxis is no worse than continuing it for 2 years in kids and teens with mild rheumatic heart disease who have already been treated.

  Recruiting Phase 3 Children's Hospital Medical Center, Cincinnati · Kampala, UG · NCT07146048

• Korea VHD Echo Study: Real-World Practice of Aortic, Mitral, and Tricuspid Valves

  This study looks at how valvular heart disease is managed in Korea by reviewing echocardiograms and medical records from multiple centers to see patterns in disease progression and treatment.

  Recruiting at 2 sites Yonsei University · Seoul, Seoul and 1 other locations · NCT07068633

• Treating severe mitral valve calcification with a specialized balloon

  This study is testing a special balloon treatment for people with severe mitral valve calcification to see if it can help them feel better when other options aren't safe or effective.

  Recruiting Prince of Wales Hospital, Shatin, Hong Kong · Shatin, New Territories · NCT06952374

• Screening for Rheumatic Heart Disease in Rural Communities

  This study is testing if using ultrasound to screen for Rheumatic Heart Disease in rural communities can help find and treat the condition early to improve health outcomes.

  Recruiting National Institute of Cardiovascular Diseases, Pakistan · Karachi, Sindh · NCT05991219

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.